Comprehensive approaches for assessing the safety of probiotic bacteria

Food Control

Volumn 108, Issue , 2020, Pages

  Pradhan, D ^a   Mallappa, Rashmi H ^a   Grover, Sunita ^a  

^a NATIONAL DAIRY RESEARCH INSTITUTE   (India)

Author keywords

Animal models; Lactobacilli; Probiotics; Safety assessment; Toxicity

Indexed keywords

EID: 85071871813     PISSN: 09567135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodcont.2019.106872     Document Type: Review

References (172)

1. Aggarwal, J., Swawami, G., Kumar, M., Probiotics and their effects on metabolic diseases: An update. Journal of Clinical and Diagnostic Research 7:1 (2013), 173–177.
2. Akagawa, Y., Ohnishi, Y., Takaya, M., Watanabe, Y., Safety assessment of probiotic bacteria, Bacillus coagulans strain SANK70258, in rats. Fundamental Toxicological Sciences 3:6 (2016), 243–250.
3. Allen, S.J., Jordan, S., Storey, M., Thornton, C.A., Gravenor, M., Garaiova, I., et al. Dietary supplementation with Lactobacilli and Bifidobacteria is well tolerated and not associated with adverse events during late pregnancy and early infancy. Journal of Nutrition 140:3 (2010), 483–488.
4. Ambalam, P., Ramoliya, J., Dave, J., Vyas, B., Safety assessment of potential probiotic strains Lactobacillus rhamnosus 231 and Lactobacillus rhamnosus v92 in mouse model. International Journal of Bioassays, 2013, 332–337.
5. Arias, L.G., Fernández, D., Sacristán, N., Arenas, R., Fresno, J.M., Tornadijo, E., Enzymatic activity, Surface hydrophobicity and biogenic amines production in lactic acid bacteria isolated from an artisanal Spanish cheese. African Journal of Microbiology Research 7:19 (2013), 2114–2118.
6. Aryantini, N.P.D., Biochemical studies on potential probiotic strains of Lactobacillus rhamnosus isolated from fermented Sumbawa mare's milk. (Doctoral dissertation), 2016.
7. Avlami, A., Kordossis, T., Vrizidis, N., Sipsas, N.V., Lactobacillus rhamnosus endocarditis complicating colonoscopy. Journal of Infection 42:4 (2001), 283–285.
8. Barlow, S., Chesson, A., Collins, J.D., Dybing, E., Flynn, A., FruijtierPölloth, C., et al. Introduction of a qualified presumption of safety (QPS) approach for assessment of selected microorganisms referred to EFSA. Opinion of the scientific committee. EFSA Journal 587 (2007), 1–16.
9. Baumgartner, A., Kueffer, M., Simmen, A., Grand, M., Relatedness of Lactobacillus rhamnosus strains isolated from clinical specimens and such from food-stuffs, humans and technology. Lebensmittel-Wissenschaft & Technologie 31:5 (1998), 489–494.
10. Benkerroum, N., Biogenic amines in dairy products: Origin, incidence, and control means. Comprehensive Reviews in Food Science and Food Safety 15:4 (2016), 801–826.
11. Bernardeau, M., Vernoux, J.P., Gueguen, M., Safety and efficacy of probiotic lactobacilli in promoting growth in post-weaning Swiss mice. International Journal of Food Microbiology 77:1 (2002), 19–27.
12. Bernardeau, M., Vernoux, J.P., Henri-Dubernet, S., Guéguen, M., Safety assessment of dairy microorganisms: The Lactobacillus genus. International Journal of Food Microbiology 126:3 (2008), 278–285.
13. Besselink, M.G.H., Van Santvoort, H.C., Buskens, E., Boermeester, M.A., van Goor, H., Timmerman, H.M., et al. Probiotic prophylaxis in predicted severe acute pancreatitis: A randomised, double-blind, placebo-controlled trial. The Lancet 371:9613 (2008), 651–659.
14. Biesiada, G., Krycińska, R., Czepiel, J., Stażyk, K., Kędzierska, J., Garlicki, A., Meningoencephalitis caused by Lactobacillus plantarum-case report. International Journal of Neuroscience, 2018, 1–9.
15. Botro, M., Mukundan, D., Lactobacillus endocarditis with prosthetic material: A case report on non-surgical management with corresponding literature review. Infectious Disease Reports, 6(3), 2014.
16. Bover-Cid, S., Holzapfel, W.H., Improved screening procedure for biogenic amine production by lactic acid bacteria. International Journal of Food Microbiology 53:1 (1999), 33–41.
17. Bunesova, V., Musilova, S., Geigerova, M., Pechar, R., Rada, V., Comparison of mupirocin-based media for selective enumeration of bifidobacteria in probiotic supplements. Journal of Microbiological Methods 109 (2015), 106–109.
18. Callaway, A., Kostrzewa, M., Willershausen, B., Schmidt, F., Thiede, B., Küpper, H., et al. Identification of lactobacilli from deep carious lesions by means of species-specific PCR and MALDI-TOF mass spectrometry. Clinical Laboratory 59 (2013), 1373–1379.
19. Cannon, J.P., Lee, T.A., Bolanos, J.T., Danziger, L.H., Pathogenic relevance of Lactobacillus: A retrospective review of over 200 cases. European Journal of Clinical Microbiology & Infectious Diseases 24:1 (2005), 31–40.
20. Chanet, V., Brazille, P., Honore, S., Michel, M., Schaeffer, A., Zarrouk, V., Lactobacillus septic arthritis. Southern Medical Journal 100:5 (2007), 531–532.
21. Chazan, B., Raz, R., Shental, T., Sprecher, H., Colodner, R., Bacteremia and pyelonephritis caused by Lactobacillus jensenii in a patient with urolithiasis, case communications. The Israel Medical Association Journal 10:2 (2008), 164–165.
22. Chery, J., Dvoskin, D., Morato, F.P., Fahoum, B., Lactobacillus fermentum, a pathogen in documented cholecystitis. International Journal of Surgery Case Reports 4:8 (2013), 662–664.
23. Chiu, Y.J., Nam, M.K., Tsai, Y.T., Huang, C.C., Tsai, C.C., Genotoxicity assessment of multispecies probiotics using reverse mutation, mammalian chromosomal aberration, and rodent micronucleus tests. Science World Journal, 2013, 2013, 254239.
24. Choi, S.S., Kang, B.Y., Chung, M.J., Kim, S.D., Park, S.H., Kim, J.S., et al. Safety assessment of potential lactic acid bacteria Bifidobacterium longum SPM1205 isolated from healthy Koreans. Journal of Microbiology 43:6 (2005), 493–498.
25. Collins, J., Van Pijkeren, J.P., Svensson, L., Claesson, M.J., Sturme, M., Li, Y., et al. Fibrinogen-binding and platelet-aggregation activities of a Lactobacillus salivarius septicaemia isolate are mediated by a novel fibrinogen-binding protein. Molecular Microbiology 85:5 (2012), 862–877.
26. Comunian, R., Daga, E., Dupré, I., Paba, A., Devirgiliis, C., Piccioni, V., et al. Susceptibility to tetracycline and erythromycin of Lactobacillus paracasei strains isolated from traditional Italian fermented foods. International Journal of Food Microbiology 138:1–2 (2010), 151–156.
27. Dani, C., Coviello, C.C., Corsini, I.I., Arena, F., Antonelli, A., Rossolini, G.M., Sepsis and probiotic therapy in newborns: Two new cases and literature review. AJP Reports, 6(1), 2016.
28. Daniel, C., Poiret, S., Goudercourt, D., Dennin, V., Leyer, G., Pot, B., Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model. Applied and Environmental Microbiology 72:9 (2006), 5799–5805.
29. Danielsen, M., Characterization of the tetracycline resistance plasmid pMD5057 from Lactobacillus plantarum 5057 reveals a composite structure. Plasmid 48:2 (2002), 98–103.
30. Darbro, B.W., Petroelje, B.K., Doern, G.V., Lactobacillus delbrueckii as the cause of urinary tract infection. Journal of Clinical Microbiology 47:1 (2009), 275–277.
31. Dekker, J.W., Wickens, K., Black, P.N., Stanley, T.V., Mitchell, E.A., Fitzharris, P., et al. Safety aspects of probiotic bacterial strains Lactobacillus rhamnosus HN001 and Bifidobacterium animalis subsp. lactis HN019 in human infants aged 0–2 years. International Dairy Journal 19:3 (2009), 149–154.
32. Derrien, M., Vaughan, E.E., Plugge, C.M., De Vos, W.M., Akkermansia muciniphila gen. Nov., sp. nov., a human intestinal mucin-degrading bacterium. International Journal of Systematic and Evolutionary Microbiology 54 (2004), 1469–1476.
33. Domann, E., Fischer, F., Glowatzki, F., Fritzenwanker, M., Hain, T., Zechel-Gran, S., et al. Draft genome sequence of Lactobacillus delbrueckii strain #22 isolated from a patient with short bowel syndrome and previous d-Lactic Acidosis and Encephalopathy. Genome Announcements, 4(4), 2016 e00747-16.
34. Domingos-Lopes, M.F.P., Stanton, C., Ross, P.R., Dapkevicius, M.L.E., Silva, C.C.G., Genetic diversity, safety and technological characterization of lactic acid bacteria isolated from artisanal Pico cheese. Food Microbiology 63 (2017), 178–190.
35. Donohue, D.C., Salminen, S., Safety of probiotic bacteria. Asia Pacific Journal of Clinical Nutrition 5 (1996), 25–28.
36. Doron, S., Snydman, D.R., Risk and safety of probiotics. Clinical Infectious Diseases 60 (2015), S129–S134.
37. DuPrey, K.M., McCrea, L., Rabinowitch, B.L., Azad, K.N., Pyelonephritis and bacteremia from Lactobacillus delbrueckii. Case Reports in Infectious Diseases, 2012, 1–3.
38. EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Rychen, G., Aquilina, G., Azimonti, G., Bampidis, V., Bastos, M.L., et al. Guidance on the characterisation of microorganisms used as feed additives or as production organisms. EFSA Journal, 16(3), 2018, e05206.
39. Elli, M., Zink, R., Rytz, A., Reniero, R., Morelli, L., Iron requirement of Lactobacillus spp. in completely chemically defined growth media. Journal of Applied Microbiology 88 (2000), 695–703.
40. Endres, J.R., Clewell, A., Jade, K.A., Farber, T., Hauswirth, J., Schauss, A.G., Safety assessment of a proprietary preparation of a novel probiotic, Bacillus coagulans, as a food ingredient. Food and Chemical Toxicology 47:6 (2009), 1231–1238.
41. Endres, J.R., Qureshi, I., Farber, T., Hauswirth, J., Hirka, G., Pasics, I., et al. One-year chronic oral toxicity with combined reproduction toxicity study of a novel probiotic, Bacillus coagulans, as a food ingredient. Food and Chemical Toxicology 49:5 (2011), 1174–1182.
42. Falkow, S., Perspectives series: Host/pathogen interactions. Invasion and intracellular sorting of bacteria: Searching for bacterial genes expressed during host/pathogen interactions. Journal of Clinical Investigation, 100(2), 1997, 239.
43. FAO/WHO, Guidelines for the evaluation of probiotics in food report of a joint FAO/WHO working group on drafting guidelines for the evaluation of probiotics in food., 2002, World Health Organization, London Ontario, Canada.
44. Feld, L., Schjorring, S., Hammer, K., Licht, T.R., Danielsen, M., Krogfelt, K., et al. Selective pressure affects transfer and establishment of a Lactobacillus plantarum resistance plasmid in the gastrointestinal environment. Journal of Antimicrobial Chemotherapy 61:4 (2008), 845–852.
45. Feng, C., Zhang, F., Wang, B., Gao, J., Wang, Y., Shao, Y., Evaluation of kanamycin and neomycin resistance in Lactobacillus plantarum using experimental evolution and whole-genome sequencing. Food Control 98 (2019), 262–267.
46. Fernandez-Murga, M.L., Sanz, Y., Safety assessment of Bacteroides uniformis CECT 7771 isolated from stools of healthy breast-fed infants. PLoS One, 11(1), 2016, e0145503.
47. Fernandez, M.F., Boris, S., Barbes, C., Safety evaluation of Lactobacillus delbrueckii subsp. lactis UO 004, a probiotic bacterium. Research in Microbiology 156:2 (2005), 154–160.
48. Floch, M.H., Probiotic safety and risk factors. Journal of Clinical Gastroenterology 47:5 (2013), 375–376.
49. Fradiani, P.A., Petrucca, A., Ascenzioni, F., Di Nucci, G., Teggi, A., Bilancini, S., et al. Endocarditis caused by Lactobacillus jensenii in an immunocompetent patient. Journal of Medical Microbiology 59:5 (2010), 607–609.
50. Franko, B., Fournier, P., Jouve, T., Malvezzi, P., Pelloux, I., Brion, J.P., et al. Lactobacillus bacteremia: Pathogen or prognostic marker?. Medecine et Maladies Infectieuses 47:1 (2017), 18–25.
51. Frenkel, E.S., Ribbeck, K., Salivary mucins protect surfaces from colonization by cariogenic bacteria. Applied and Environmental Microbiology 81:1 (2015), 332–338.
52. Frias, R., Ouwehand, A., Spillmann, T., Vankerckhoven, V., Hewicker-Trautwein, M., Salminen, S., et al. Effect of clinical and probiotic Lactobacillus rhamnosus strains on intestinal permeability and bacterial translocation in healthy and colitic rats. Food Research International 42:5 (2009), 636–640.
53. Fuller, R., A review: Probiotics in man and animals. Journal of Applied Bacteriology 66 (1989), 365–378.
54. Ganguly, N.K., Bhattacharya, S.K., Sesikeran, B., Nair, G.B., Ramakrishna, B.S., Sachdev, H.P.S., et al. ICMR-DBT guidelines for evaluation of probiotics in food. Indian Journal of Medical Research 134:1 (2011), 22–25.
55. Gonzalez Pereyra, M.L., Dogi, C., Torres Lisa, A., Wittouck, P., Ortíz, M., Escobar, F., et al. Genotoxicity and cytotoxicity evaluation of probiotic Saccharomyces cerevisiae RC016: A 60‐day subchronic oral toxicity study in rats. Journal of Applied Microbiology 117:3 (2014), 824–833.
56. de Groote, M.A., Frank, D.N., Dowell, E., Glode, M.P., Pace, N.R., Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatric Journal of Infectious Disease 24 (2005), 278–280.
57. Gueimonde, M., Sanchez, B., Clara, G., Margolles, A., Antibiotic resistance in probiotic bacteria. Frontiers in Microbiology, 4, 2013, 202.
58. Harding-Theobald, E., Maraj, B., Spontaneous Bacterial Peritonitis due to Lactobacillus paracasei in Cirrhosis. Case reports in gastrointestinal medicine., 2018 2018.
59. Harty, D.W.S., Patrikakise, M., Hume, E.B.H., Oakey, H.J., Knox, K.W., The aggregation of human platelets by Lactobacillus species. Journal of General Microbiology, 139, 1993 2945-295.
60. Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology 11:8 (2014), 506–514.
61. Hirose, Y., Murosaki, S., Yamamoto, Y., Muroyama, K., Miwa, Y., Fujishima, A., et al. Safety studies of LP20 powder produced from heat-killed Lactobacillus plantarum L-137. Regulatory Toxicology and Pharmacology 54:3 (2009), 214–220.
62. Hojsak, I., Shamir, R., Probiotic bacteria and their effect on human health and well-being. World Review of Nutrition & Dietetics 107 (2013), 161–170.
63. Hong, H.A., Huang, J.M., Khaneja, R., Hiep, L.V., Urdaci, M.C., Cutting, S.M., The safety of Bacillus subtilis and Bacillus indicus as food probiotics. Journal of Applied Microbiology 105:2 (2008), 510–520.
64. Huang, Y., Kotula, L., Adams, M.C., The in vivo assessment of safety and gastrointestinal survival of an orally administered novel probiotic, Propionibacterium jensenii 702, in a male Wistar rat model. Food and Chemical Toxicology 41:12 (2003), 1781–1787.
65. Hummel, A.S., Hertel, C., Holzapfel, W.H., Franz, C.M., Antibiotic resistances of starter and probiotic strains of lactic acid bacteria. Applied and Environmental Microbiology 73:3 (2007), 730–739.
66. Isa, K., Oka, K., Beauchamp, N., Sato, M., Wada, K., Ohtani, K., et al. Safety assessment of the Clostridium butyricum MIYAIRI 588® probiotic strain including evaluation of antimicrobial sensitivity and presence of Clostridium toxin genes in vitro and teratogenicity in vivo. Human & Experimental Toxicology 35:8 (2016), 818–832.
67. Ishibashi, N., Yamazaki, S., Probiotics and safety. American Journal of Clinical Nutrition 73 (2001), 465S–470S.
68. Jacobsen, L., Wilcks, A., Hammer, K., Huys, G., Gevers, D., Andersen, S.R., Horizontal transfer of tet(M) and erm(B) resistance plasmids from food strains of Lactobacillus plantarum to Enterococcus faecalis JH2-2 in the gastrointestinal tract of gnotobiotic rats. FEMS Microbiology Ecology 59:1 (2007), 158–166.
69. Jafari, E., Vahedi, H., Merat, S., Momtahen, S., Riahi, A., Therapeutic effects, tolerability and safety of a multi-strain probiotic in Iranian adults with irritable bowel syndrome and bloating. Archives of Iranian Medicine 17:7 (2014), 466–470.
70. Jampaphaeng, K., Cocolin, L., Maneerat, S., Selection and evaluation of functional characteristics of autochthonous lactic acid bacteria isolated from traditional fermented stinky bean (Sataw-Dong). Annals of Microbiology 67:1 (2017), 25–36.
71. Jia, X., Wang, W., Song, Y., Li, N., A 90-day oral toxicity study on a new strain of Lactobacillus paracasei in rats. Food and Chemical Toxicology 49:5 (2011), 1148–1151.
72. Jones, M.L., Martoni, C.J., Tamber, S., Parent, M., Prakash, S., Evaluation of safety and tolerance of microencapsulated Lactobacillus reuteri NCIMB 30242 in a yogurt formulation: A randomized, placebo controlled, double-blind study. Food and Chemical Toxicology 50:6 (2012), 2216–2223.
73. Kabeir, B.M., Yazid, A.M., Stephenie, W., Nazrul Hakim, M., Muhammad Anas, O., Shuhaimi, M., Safety evaluation of Bifidobacterium pseudocatenulatum G4 as assessed in BALB/c mice. Letters in Applied Microbiology 46:1 (2008), 32–37.
74. Kato, K., Funabashi, N., Takaoka, H., Kohno, H., Kishimoto, T., Nakatani, Y., et al. Lactobacillus paracasei endocarditis in a consumer of probiotics with advanced and severe bicuspid aortic valve stenosis complicated with diffuse left ventricular mid-layer fibrosis. International Journal of Cardiology 224 (2016), 157–161.
75. Khalkhali, S., Mojgani, N., In vitro and in vivo safety analysis of Enterococcus faecium 2C isolated from human breast milk. Microbial Pathogenesis 116 (2018), 73–77.
76. Khan, F., Khakoo, R., Failinger, C., Managing embolic myocardial infarction in infective endocarditis: Current options. Journal of Infection 51:3 (2005), e101–e105.
77. Killer, J., Marounek, M., Fermentation of mucin by bifidobacteria from rectal samples of humans and rectal and intestinal samples of animals. Folia Microbiologica 56:2 (2011), 85–89.
78. Kirjavainen, P.V., Tuomola, E.M., Crittenden, R.G., Ouwehand, A.C., Harty, D.W.S., Morris, L.F., et al. In-vitro adhesion and platelet aggregation properties of bacteremia-associated Lactobacilli. Infection and Immunity 67:5 (1999), 2653–2655.
79. Korpela, R., Moilanen, E., Saxelin, M., Vapaasalo, H., Lactobacillus rhamnosus GG (ATCC 53013) and platelet aggregation in vitro. International Journal of Food Microbiology 37 (1997), 83–86.
80. Kothari, D., Patel, S., Kim, S.K., Probiotic supplements might not be universally-effective and safe: A review. Biomedicine & Pharmacotherapy 111 (2019), 537–547.
81. Koyama, S., Fujita, H., Shimosato, T., Kamijo, A., Ishiyama, Y., Yamamoto, E., et al. Septicemia from Lactobacillus rhamnosus GG, from a probiotic enriched yogurt, in a patient with autologous stem cell transplantation. Probiotics and antimicrobial proteins 11:1 (2018), 295–298.
82. Kumar, R., Grover, S., Batish, V.K., Molecular identification and typing of putative probiotic indigenous Lactobacillus plantarum strain Lp91 of human origin by specific primed-PCR assays. Probiotics and Antimicrobial Proteins 3 (2011), 186–193.
83. Ladero, V., Calles-Enríquez, M., Fernández, M., Alvarez, M., Toxicological effects of dietary biogenic amines. Current Nutrition & Food Science 6:2 (2010), 145–156.
84. Lakshmi, S.G., Jayanthi, N., Saravanan, M., Ratna, M.S., Safety assesment of Bacillus clausii UBBC07, a spore forming probiotic. Toxicology reports 4 (2017), 62–71.
85. Lara-Villoslada, F., Sierra, S., Díaz-Ropero, M.P., Olivares, M., Xaus, J., Safety assessment of the human milk-isolated probiotic Lactobacillus salivarius CECT5713. Journal of Dairy Science 90:8 (2007), 3583–3589.
86. Lara-Villoslada, F., Sierra, S., Martín, R., Delgado, S., Rodríguez, J.M., Olivares, M., et al. Safety assessment of two probiotic strains, Lactobacillus coryniformis CECT5711 and Lactobacillus gasseri CECT5714. Journal of Applied Microbiology 103:1 (2007), 175–184.
87. Licht, T.R., Wilcks, A., Conjugative gene transfer in the gastrointestinal environment. Advances in Applied Microbiology 58 (2005), 77–95.
88. Li, B., Jin, D., Etareri Evivie, S., Li, N., Yan, F., Zhao, L., et al. Safety assessment of Lactobacillus helveticus KLDS1. 8701 based on whole genome sequencing and oral toxicity studies. Toxins, 9(10), 2017, 301.
89. Lin, Y.C., Chen, Y.T., Chen, M.J., Lack of mutagenicity, genotoxicity and developmental toxicity in safety assessment tests of Lactobacillus maliAPS1. PLoS One, 13(12), 2018, e0208881.
90. Li, B., Zhan, M., Evivie, S.E., Jin, D., Zhao, L., Chowdhury, S., et al. Evaluating the safety of potential probiotic Enterococcus durans KLDS6. 0930 using whole genome sequencing and oral toxicity study. Frontiers in Microbiology, 9, 2018, 1943.
91. Macfarlane, S., Woodmansey, E.J., Macfarlane, G.T., Colonization of mucin by human intestinal bacteria and establishment of biofilm communities in a two-stage continuous culture system. Applied and Environmental Microbiology 71:11 (2005), 7483–7492.
92. Maldonado-Lobón, J.A., Díaz-López, M.A., Carputo, R., Duarte, P., Díaz-Ropero, M.P., Valero, A.D., et al. Lactobacillus fermentum CECT 5716 reduces Staphylococcus load in the breastmilk of lactating mothers suffering breast pain: A randomized controlled trial. Breastfeeding Medicine 10:9 (2015), 425–432.
93. Mangalat, N., Liu, Y., Fatheree, N.Y., Ferris, M.J., Van Arsdall, M.R., Chen, Z., et al. Safety and tolerability of Lactobacillus reuteri DSM 17938 and effects on biomarkers in healthy adults: Results from a randomized masked trial. PLoS One, 7(9), 2012, 43910.
94. Maragkoudakis, P.A., Zoumpopoulou, G., Miaris, C., Kalantzopoulos, G., Pot, B., Tsakalidou, E., Probiotic potential of Lactobacillus strains isolated from dairy products. International Dairy Journal 16:3 (2006), 189–199.
95. McVay, M.R., Boneti, C., Habib, C.M., Keller, J.E., Kokoska, E.R., Jackson, R.J., et al. Formula fortified with live probiotic culture reduces pulmonary and gastrointestinal bacterial colonization and translocation in a newborn animal model. Journal of Pediatric Surgery 43:1 (2008), 25–29.
96. Merenstein, D.J., Tan, T.P., Molokin, A., Smith, K.H., Roberts, R.F., Shara, N.M., et al. Safety of Bifidobacterium animalis subsp. lactis (B. lactis) strain BB-12-supplemented yogurt in healthy adults on antibiotics: a phase I safety study. Gut Microbes 6:1 (2015), 66–77.
97. Mogilner, J.G., Srugo, I., Lurie, M., Shaoul, R., Coran, A.G., Shiloni, E., et al. Effect of probiotics on intestinal regrowth and bacterial translocation after massive small bowel resection in a rat. Journal of Pediatric Surgery 42:8 (2007), 1365–1371.
98. Monteagudo-Mera, A., Rodríguez-Aparicio, L., Rúa, J., Martínez-Blanco, H., Navasa, N., García-Armesto, M.R., et al. In vitro evaluation of physiological probiotic properties of different lactic acid bacteria strains of dairy and human origin. Journal of Functional Foods 4:2 (2012), 531–541.
99. Morovic, W., Roper, J.M., Smith, A.B., Mukerji, P., Stahl, B., Rae, J.C., et al. Safety evaluation of HOWARU® Restore (Lactobacillus acidophilus NCFM, Lactobacillus paracaseiLpc-37, Bifidobacterium animalis subsp. lactis Bl-04 and B. lactis Bi-07) for antibiotic resistance, genomic risk factors, and acute toxicity. Food and Chemical Toxicology 110 (2017), 316–324.
100. Mukerji, P., Roper, J.M., Stahl, B., Smith, A.B., Burns, F., Rae, J.C., et al. Safety evaluation of AB-LIFE® (Lactobacillus plantarum CECT 7527, 7528 and 7529): Antibiotic resistance and 90-day repeated-dose study in rats. Food and Chemical Toxicology 92 (2016), 117–128.
101. Muñoz-Atienza, E., Gómez-Sala, B., Araújo, C., Campanero, C., Campo, R., Hernández, P.E., et al. Antimicrobial activity, antibiotic susceptibility and virulence factors of Lactic Acid Bacteria of aquatic origin intended for use as probiotics in aquaculture. BMC Microbiology, 13(1), 2013, 15.
102. Munoz, P., Bouza, E., Cuenca-Estrella, M., Eiros, J.M., Pérez, M.J., Sánchez-Somolinos, M., et al. Saccharomyces cerevisiae fungemia: An emerging infectious disease. Clinical Infectious Diseases 40:11 (2005), 1625–1634.
103. Nishijima, T., Teruya, K., Yanase, M., Tamori, Y., Mezaki, K., Oka, S., Infectious Endocarditis caused by Lactobacillus acidophilus in a patient with mistreated dental caries. Internal Medicine 51:12 (2012), 1619–1621.
104. Nithya, V., Muthukumar, S.P., Halami, P.M., Safety assessment of Bacillus licheniformisMe1 isolated from milk for probiotic application. International Journal of Toxicology 31:3 (2012), 228–237.
105. OECD, Organization for economic cooperation and development: OECD guidelines for the testing of chemicals. Test guideline 408. Repeated dose 90-day oral toxicity study in rodent. 1995, OECD, Paris.
106. OECD, Test No. 423: Acute oral toxicity - acute toxic class method. 2002, OECD Publishing, Paris https://doi.org/10.1787/9789264071001-en.
107. OECD, Guideline for the testing of chemicals draft consultant's proposal. Test guideline 452: Chronic toxicity studies, 8, 2008 Retrieved from www.oecd.org/chemicalsafety/testing/41753317.pdf.
108. OECD. Organization for Economic Co-operation and Development, OECD guideline for the testing of chemicals: Repeated dose 28-day oral toxicity study in rodents. 1995.
109. Osman, N., Adawi, D., Ahrné, S., Jeppsson, B., Molin, G., Endotoxin- and d-galactosamine-induced liver injury improved by the administration of Lactobacillus, Bifidobacterium and blueberry. Digestive and Liver Disease 39:9 (2007), 849–856.
110. Owaga, E.E., Chen, M.J., Chen, W.Y., Chen, C.W., Hsieh, R.H., Oral toxicity evaluation of kefir isolated Lactobacillus kefiranofaciens M1 in Sprague–Dawley rats. Food and Chemical Toxicology 70 (2014), 157–162.
111. Pang, X., Hua, X., Yang, Q., Ding, D., Che, C., Cui, L., et al. Inter-species transplantation of gut microbiota from human to pigs. The ISME Journal, 1(2), 2007, 156.
112. Papadimitriou, K., Zoumpopoulou, G., Foligné, B., Alexandraki, V., Kazou, M., Pot, B., et al. Discovering probiotic microorganisms: In-vitro, in-vivo, genetic and omics approaches. Frontiers in Microbiology, 6(58), 2015.
113. Pararajasingam, A., Uwagwu, J., Lactobacillus: The not so friendly bacteria. BMJ Case Reports, 2017(bcr-2016), 2017.
114. Park, J.H., Lee, Y.H., Moon, E.P., Seok, S.H., Baek, M.W., Lee, H.Y., Safety Assessment of Lactobacillus fermentum PL9005, a potential probiotic lactic acid bacterium in mice. Journal of Microbiology and Biotechnology 15:3 (2005), 603–608.
115. Patterson, J.K., Lei, X.G., Miller, D.D., The pig as an experimental model for elucidating the mechanisms governing dietary influence on mineral absorption. Experimental Biology and Medicine 233:6 (2008), 651–664.
116. Pavan, S., Desreumaux, P., Mercenier, A., Use of mouse models to evaluate the persistence, safety, and immune modulation capacities of Lactic Acid Bacteria. Clinical and Diagnostic Laboratory Immunology 10:4 (2003), 696–701.
117. Pircher, A., Bauer, F., Paulsen, P., Formation of cadaverine, histamine, putrescine and tyramine by bacteria isolated from meat, fermented sausages and cheeses. European Food Research and Technology 226:1–2 (2007), 225–231.
118. Pradhan, D., Assessing preclinical safety of indigenous probiotic L. fermentum Lf1 strains., 2017 (Doctoral dissertation, NDRI, Karnal).
119. Pradhan, D., Singh, R., Tyagi, A., Rashmi, H.M., Batish, V.K., Grover, S., Assessing the safety and efficacy of Lactobacillus plantarum MTCC 5690 and Lactobacillus fermentum MTCC 5689 in colitis mouse model. Probiotics and antimicrobial proteins, 2018, 1–11.
120. Pradhan, D., Singh, R., Tyagi, A., Rashmi, H.M., Batish, V.K., Grover, S., Assessing safety of Lactobacillus plantarum MTCC 5690 and Lactobacillus fermentum MTCC 5689 using in vitro approaches and an in vivo murine model. Regulatory Toxicology and Pharmacology 101 (2019), 1–11.
121. Rasul, S., Farhat, F., Ramsahai, S., Delapenha, R., Shah, N., Pyelonephritis and bacteremia from Lactobacillus acidophilus. Journal of Medical Cases 3:4 (2012), 223–225.
122. Ricci, A., Allende, A., Bolton, D., Chemaly, M., Davies, R., Girones, R.,R., et al. Update of the list of QPS‐recommended biological agents intentionally added to food or feed as notified to EFSA 5: Suitability of taxonomic units notified to EFSA until september 2016. EFSA Journal, 15(3), 2017.
123. Rogasi, P.G., Viganò, S., Pecile, P., Leoncini, F., Lactobacillus casei pneumonia and sepsis in a patient with AIDS. Case report and review of the literature. Annual Italian Medical International 13:3 (1998), 180–182.
124. Roy, U., Jessani, L.G., Rudramurthy, S.M., Gopalakrishnan, R., Dutta, S., Chakravarty, C., et al. Seven cases of Saccharomyces fungaemia related to use of probiotics. Mycoses 60:6 (2017), 375–380.
125. Ruiz-Moyano, S., Tao, N., Underwood, M.A., Mills, D.A., Rapid discrimination of Bifidobacterium animalis subspecies by matrix-assisted laser desorption ionization-time of flight mass spectrometry. Food Microbiology 30:2 (2012), 432–437.
126. Salminen, S., Marteau, P., Safety of probiotic lactic acid bacteria and other probiotics. Lactic 97 (Proceedings). Lactic 97 (1997), 71–72.
127. Salminen, M.K., Rautelin, H., Tynkkynen, S., Poussa, T., Saxelin, M., Valtonen, V., et al. Lactobacillus Bacteremia, species identification, and antimicrobial susceptibility of 85 blood isolates. Clinical Infectious Diseases 42:5 (2006), 35–44.
128. Salminen, S., Von Wright, A., Morelli, L., Marteau, P., Brassart, D., de Vos, W.M., et al. Demonstration of safety of probiotics-a review. International Journal of Food Microbiology 44:1–2 (1998), 93–106.
129. Sanders, M.E., Akkermans, L.M.A., Haller, D., Hammerman, C., Heimbach, J.T., Hörmannsperger, G., et al. Safety assessment of probiotics for human use. Gut Microbes 1:3 (2010), 164–185.
130. Saxelin, M., Chuang, N.H., Chassy, B., Rautelin, H., Mäkelä, P.H., Salminen, S., et al. Lactobacilli bacteremia in southern Finland, 1989–1992. Clinical Infectious Diseases 22:3 (1996), 564–566.
131. Scott, K.A., Ida, M., Peterson, V.L., Prenderville, J.A., Moloney, G.M., Izumo, T., et al. Revisiting Metchnikoff: Age-related alterations in microbiota-gut-brain axis in the mouse. Brain, Behavior, and Immunity 65 (2017), 20–32.
132. Senan, S., Prajapati, J.B., Joshi, C.G., Feasibility of genome-wide screening for biosafety assessment of probiotics: A case study of Lactobacillus helveticus MTCC 5463. Probiotics and antimicrobial proteins 7:4 (2015), 249–258.
133. Shokryazdan, P., Jahromi, M.F., Liang, J.B., Kalavathy, R., Sieo, C.C., Ho, Y.W., Safety assessment of two new Lactobacillus strains as probiotic for human using a rat model. PLoS One, 11(7), 2016.
134. Shu, Q., Zhou, J.S., Rutherfurd, K.J., Birtles, M.J., Prasad, J., Gopal, P.K., et al. Probiotic lactic acid bacteria (Lactobacillus acidophilus HN017, Lactobacillus rhamnosus HN001 and Bifidobacterium lactisHN019) have no adverse effects on the health of mice. International Dairy Journal 9:11 (1999), 831–836.
135. Simkins, J., Kaltsas, A., Currie, B.P., Investigation of inpatient probiotic use at an academic medical center. International Journal of Infectious Diseases 17:5 (2013), 321–324.
136. Solano-Aguilar, G., Dawson, H., Restrepo, M., Andrews, K., Vinyard, B., Urban, J.F., Detection of Bifidobacterium animalis subsp. lactis (Bb12) in the intestine after feeding of sows and their piglets. Applied and Environmental Microbiology 74:20 (2008), 6338–6347.
137. Somayaji, R., Lynch, T., Powell, J.N., Gregson, D., Remote transient Lactobacillus animalis bacteremia causing prosthetic hip joint infection: A case report. BMC Infectious Diseases, 16, 2016, 634.
138. Sorokulova, I.B., Pinchuk, I.V., Denayrolles, M., Osipova, I.G., Huang, J.M., Cutting, S.M., et al. The safety of two Bacillus probiotic strains for human use. Digestive Diseases and Sciences 53:4 (2008), 954–963.
139. de Souza Leone, R., de Andrade, E.F., Ellendersen, L.N., da Cunha, A.T., Martins, A.M.C., Granato, D., et al. Evaluation of dried yacon (Smallanthus sonchifolius) as an efficient probiotic carrier of Lactobacillus casei LC-01. LWT-Food Science and Technology 75 (2017), 220–226.
140. Srinivasan, R., Meyer, R., Padmanabhan, R., Britto, J., Clinical safety of Lactobacillus casei shirota as a probiotic in critically ill children. Journal of Pediatric Gastroenterology and Nutrition 42:2 (2006), 171–173.
141. Steppe, M., Van Nieuwerburgh, F., Vercauteren, G., Boyen, F., Eeckhaut, V., Deforce, D., et al. Safety assessment of the butyrate-producing Butyricicoccus pullicaecorum strain 25-3 T, a potential probiotic for patients with inflammatory bowel disease, based on oral toxicity tests and whole genome sequencing. Food and Chemical Toxicology 72 (2014), 129–137.
142. Suarez-Garcia, I., Sanchez-Garcia, A., Soler, L., Malmierca, E., Gómez-Cerezo, J., Lactobacillus jensenii bacteremia and endocarditis after dilatation and curettage: Case report and literature review. Infection 40:2 (2012), 219–222.
143. Sudha, M.R., Safety assessment studies of probiotic Saccharomyces boulardii strain Unique 28 in Sprague-Dawley rats. Beneficial Microbes 2:3 (2011), 221–227.
144. Sullivan, A., Nord, C.E., Probiotic lactobacilli and bacteraemia in Stockholm. Scandinavian Journal of Infectious Diseases 38 (2006), 327–331.
145. Szabo, N.J., Dolan, L.C., Burdock, G.A., Shibano, T., Sato, S.I., Suzuki, H., et al. Safety evaluation of Lactobacillus pentosus strain b240. Food and Chemical Toxicology 49:1 (2011), 251–258.
146. Tan, Q., Xu, H., Aguilar, Z.P., Peng, S., Dong, S., Wang, B., et al. Safety assessment and probiotic evaluation of Enterococcus faecium YF5 isolated from sourdough. Journal of Food Science, 78(4), 2013.
147. Tapiovaara, L., Specific probiotics in the upper respiratory tract: Colonization, efficacy and safety: With a focus on Lactobacillus rhamnosus GG. Doctoral dissertation, 2016, Faculty of Medicine, Institute of Clinical Medicine, University of Helsinki, Finland.
148. Todorov, S.D., Stojanovski, S., Iliev, I., Moncheva, P., Nero, L.A., Ivanova, I.V., Technology and safety assessment for lactic acid bacteria isolated from traditional Bulgarian fermented meat product “lukanka”. Brazilian Journal of Microbiology 48 (2017), 576–586.
149. Tompkins, T.A., Hagen, K.E., Wallace, T.D., Fillion-Forte, V., Safety evaluation of two bacterial strains used in Asian probiotic products. Canadian Journal of Microbiology 54:5 (2008), 391–400.
150. Toomey, N., Monaghan, A., Fanning, S., Bolton, D., Transfer of antibiotic resistance marker genes between Lactic Acid Bacteria in model rumen and plant environments. Applied and Environmental Microbiology 75:10 (2009), 3146–3152.
151. Tsai, C.C., Leu, S.F., Huang, Q.R., Chou, L.C., Huang, C.C., Safety evaluation of multiple strains of Lactobacillus plantarum and Pediococcus pentosaceus in Wistar rats based on the Ames test and a 28-day feeding study. Science World Journal, 2014, 2014, 928652.
152. Tseng, W.T., Shih, T.W., Liu, S.H., Pan, T.M., Safety and mutagenicity evaluation of Vigiis 101 powder made from Lactobacillus paracasei subsp. paracasei NTU 101. Regulatory Toxicology and Pharmacology 71:2 (2015), 148–157.
153. Uchida, M., Tsuboi, H., Takahashi, M., Nemoto, A., Seki, K., Tsunoo, H., et al. Safety of high doses of Propionibacterium freudenreichii ET-3 culture in healthy adult subjects. Regulatory Toxicology and Pharmacology 60:2 (2011), 262–267.
154. Ulsemer, P., Toutounian, K., Kressel, G., Schmidt, J., Karsten, U., Hahn, A., et al. Safety and tolerance of Bacteroides xylanisolvens DSM 23964 in healthy adults. Beneficial Microbes 3:2 (2012), 99–111.
155. Vahabnezhad, E., Mochon, A.B., Wozniak, L.J., Ziring, D.A., Lactobacillus bacteremia associated with probiotic use in a pediatric patient with ulcerative colitis. Journal of Clinical Gastroenterology 47:5 (2013), 437–439.
156. Vandenplas, Y., Huys, G., Daube, G., Probiotics: An update. Jornal de Pediatria 91:1 (2015), 6–21.
157. Vankerckhoven, V., Huys, G., Vancanneyt, M., Snauwaert, C., Swings, J., Klare, I., et al. Genotypic diversity, antimicrobial resistance, and virulence factors of human isolates and probiotic cultures constituting two intraspecific groups of Enterococcus faecium isolates. Applied and Environmental Microbiology 74:14 (2008), 4247–4255.
158. Van den Nieuwboer, M., Brummer, R.J., Guarner, F., Morelli, L., Cabana, M., Claassen, E., Safety of probiotics and synbiotics in children under 18 years of age. Beneficial Microbes 6:5 (2015), 615–630.
159. Von Wright, A., Salminen, S., Probiotics: Established effects and open questions. European Journal of Gastroenterology and Hepatology 11:11 (1999), 1195–1198.
160. Wang, Y., Chen, C., Ai, L., Zhou, F., Zhou, Z., Wang, L., et al. Complete genome sequence of the probiotic Lactobacillus plantarum ST-III. Journal of Bacteriology 193:1 (2011), 313–314.
161. Wind, R.D., Tolboom, H., Klare, I., Huys, G., Knol, J., Tolerance and safety of the potentially probiotic strain Lactobacillus rhamnosus PRSF-l477: A randomised, double-blind placebo-controlled trial in healthy volunteers. British Journal of Nutrition 104:12 (2010), 1806–1816.
162. Wolz, M., Schaefer, J., “Swiss cheese–like” brain due to Lactobacillus rhamnosus. Neurology, 70(12), 2008, 979.
163. Xu, M., Wang, J., Wang, N., Sun, F., Wang, L., Liu, X.H., The efficacy and safety of the probiotic bacterium Lactobacillus reuteri DSM 17938 for infantile colic: A meta-analysis of randomized controlled trials. PLoS One, 10(10), 2015, e0141445.
164. Yakabe, T., Moore, E.L., Yokota, S., Sui, H., Nobuta, Y., Fukao, M., et al. Safety assessment of Lactobacillus brevis KB290 as a probiotic strain. Food and Chemical Toxicology 47:10 (2009), 2450–2453.
165. Zhang, W., Azevedo, M.S., Wen, K., Gonzalez, A., Saif, L.J., Li, G., et al. Probiotic Lactobacillus acidophilus enhances the immunogenicity of an oral rotavirus vaccine in gnotobiotic pigs. Vaccine 26:29–30 (2008), 3655–3661.
166. Zhang, Z.Y., Liu, C., Zhu, Y.Z., Wei, Y.X., Tian, F., Zhao, G.P., et al. Safety assessment of Lactobacillus plantarum JDM1 based on the complete genome. International Journal of Food Microbiology 153:1–2 (2012), 166–170.
167. Zhang, H., Sun, J., Wang, Q.Y., He, Y.T., Gu, H.Y., Guo, H.Y., et al. Safety Assessment of Lactobacillus salivarius REN, a probiotic strain isolated from Centenarian feces. Food Science and Technology Research 19:6 (2013), 1037–1043.
168. Zhou, J.S., Gopal, P.K., Gill, H.S., Potential probiotic lactic acid bacteria Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019) do not degrade gastric mucin in vitro. International Journal of Food Microbiology 63:1–2 (2001), 81–90.
169. Zhou, J.S., Rutherfurd, K.J., Gill, H.S., Inability of Probiotic bacterial strains Lactobacillus rhamnosusHN001 and Bifidobacterium lactis HN019 to induce human platelet aggregation In-Vitro. Journal of Food Protection 68:11 (2005), 2459–2464.
170. Zhou, J.S., Shu, Q., Rutherfurd, K.J., Prasad, J., Birtles, M.J., Gopal, P.K., et al. Safety assessment of potential probiotic lactic acid bacterial strains Lactobacillus rhamnosus HN001, Lb. acidophilus HN017, and Bifidobacterium lactis HN019 in BALB/c mice. International Journal of Food Microbiology 56:1 (2000), 87–96.
171. Zhou, J.S., Shu, Q., Rutherfurd, K.J., Prasad, J., Gopal, P.K., Gill, H.S., Acute oral toxicity and bacterial translocation studies on potentially probiotic strains of lactic acid bacteria. Food and Chemical Toxicology 38:2–3 (2000), 153–161.
172. Zoumpopoulou, G., Tzouvanou, A., Mavrogonatou, E., Alexandraki, V., Georgalaki, M., Anastasiou, R., et al. Probiotic features of lactic acid bacteria isolated from a diverse pool of traditional Greek dairy products regarding specific strain-host interactions. Probiotics and Antimicrobial Proteins 10:2 (2018), 313–322.